Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148


Outcomes of surgery versus chemoradiotherapy in patients with clinical or pathologic stage N3 non-small cell lung cancer.

Raman V, Jawitz OK, Yang CJ, Voigt SL, Wang H, D'Amico TA, Harpole DH, Tong BC.

J Thorac Cardiovasc Surg. 2019 Sep 9. pii: S0022-5223(19)31760-X. doi: 10.1016/j.jtcvs.2019.08.033. [Epub ahead of print]


Outcomes for Surgery in Large Cell Lung Neuroendocrine Cancer.

Raman V, Jawitz OK, Yang CJ, Voigt SL, Tong BC, D'Amico TA, Harpole DH.

J Thorac Oncol. 2019 Sep 23. pii: S1556-0864(19)33306-4. doi: 10.1016/j.jtho.2019.09.005. [Epub ahead of print]


Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting.

Gill RR, Tsao AS, Kindler HL, Richards WG, Armato SG 3rd, Francis RJ, Gomez DR, Dahlberg S, Rimner A, Simone CB 2nd, de Perrot M, Blumenthal G, Adjei AA, Bueno R, Harpole DH Jr, Hesdorffer M, Hirsch FR, Pass HI, Yorke E, Rosenzweig K, Burt B, Fennell DA, Lindwasser W, Malik S, Peikert T, Mansfield AS, Salgia R, Yang H, Rusch VW, Nowak AK.

J Thorac Oncol. 2019 Oct;14(10):1718-1731. doi: 10.1016/j.jtho.2019.08.012. Epub 2019 Aug 27.


Surgery is Associated with Survival Benefit in T4a Esophageal Adenocarcinoma: A National Analysis.

Raman V, Jawitz OK, Voigt SL, Farrow NE, Yang CJ, D'Amico TA, Harpole DH Jr.

Ann Thorac Surg. 2019 Jul 26. pii: S0003-4975(19)31060-4. doi: 10.1016/j.athoracsur.2019.05.091. [Epub ahead of print]


The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.

Gomez DR, Rimner A, Simone CB 2nd, Cho BCJ, de Perrot M, Adjei AA, Bueno R, Gill RR, Harpole DH Jr, Hesdorffer M, Hirsch FR, Jackson AA, Pass HI, Rice DC, Rusch VW, Tsao AS, Yorke E, Rosenzweig K.

J Thorac Oncol. 2019 Jul;14(7):1172-1183. doi: 10.1016/j.jtho.2019.03.030. Epub 2019 May 22. Review.


Flow Cytometry Characterization of Cerebrospinal Fluid Monocytes in Patients With Postoperative Cognitive Dysfunction: A Pilot Study.

Berger M, Murdoch DM, Staats JS, Chan C, Thomas JP, Garrigues GE, Browndyke JN, Cooter M, Quinones QJ, Mathew JP, Weinhold KJ, Amundsen CL, Bengali S, Brigman BE, Bullock WM, Carter J, Chapman J, Cheong Yee Ching V, Cohen HJ, Colin B, D'Amico TA, Devinney MJ, DeOrio JK, Ellet T, Esclamado RM, Ferrandino MN, Gadsden J, Guercio J, Habib A, Harpole DH, Hartwig MG, Iboaya E, Inman BA, Khan A, Lagoo-Deenadayalan S, Lee PS, Lee WT, Lemm J, Levinson H, Mantyh C, McDonagh DL, Migaly J, Mithani SK, Moretti E, Moul JW, Newman MF, Ni K, Ohlendorf B, Perez A, Peterson AC, Ponussamy V, Preminger GM, Robertson CN, Roman SA, Runyon S, Sandler A, Scheri RP, Smith SK, Talbot L, Thacker JKM, Tong BC, Tu A, Vaslef SN, Waldron N, Wang X, Whitson H, Wickenheisser V, Young C; MADCO-PC Study Team; Markers of Alzheimer’s Disease and neuroCognitive Outcomes after Perioperative Care (MADCO-PC).

Anesth Analg. 2019 Nov;129(5):e150-e154. doi: 10.1213/ANE.0000000000004179.


Adjuvant Therapy for Patients With Early Large Cell Lung Neuroendocrine Cancer: A National Analysis.

Raman V, Jawitz OK, Yang CJ, Tong BC, D'Amico TA, Berry MF, Harpole DH Jr.

Ann Thorac Surg. 2019 Aug;108(2):377-383. doi: 10.1016/j.athoracsur.2019.03.053. Epub 2019 Apr 18.


A One-Step Autotransplantation Can Facilitate the Excision of Cardiac Tumors Invading the Lung.

Barac YD, Harpole DH Jr, Ghadimi K, Milano CA.

Semin Thorac Cardiovasc Surg. 2019 Autumn;31(3):475-476. doi: 10.1053/j.semtcvs.2019.01.012. Epub 2019 Jan 16. No abstract available.


Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.

Tsao AS, Lindwasser OW, Adjei AA, Adusumilli PS, Beyers ML, Blumenthal GM, Bueno R, Burt BM, Carbone M, Dahlberg SE, de Perrot M, Fennell DA, Friedberg J, Gill RR, Gomez DR, Harpole DH Jr, Hassan R, Hesdorffer M, Hirsch FR, Hmeljak J, Kindler HL, Korn EL, Liu G, Mansfield AS, Nowak AK, Pass HI, Peikert T, Rimner A, Robinson BWS, Rosenzweig KE, Rusch VW, Salgia R, Sepesi B, Simone CB 2nd, Sridhara R, Szlosarek P, Taioli E, Tsao MS, Yang H, Zauderer MG, Malik SM.

J Thorac Oncol. 2018 Nov;13(11):1655-1667. doi: 10.1016/j.jtho.2018.08.2036. Epub 2018 Sep 25.


Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung Carcinoma.

Yu H, Chen Z, Ballman KV, Watson MA, Govindan R, Lanc I, Beer DG, Bueno R, Chirieac LR, Chui MH, Chen G, Franklin WA, Gandara DR, Genova C, Brovsky KA, Joshi MM, Merrick DT, Richards WG, Rivard CJ, Harpole DH, Tsao MS, van Bokhoven A, Shepherd FA, Hirsch FR.

J Thorac Oncol. 2019 Jan;14(1):25-36. doi: 10.1016/j.jtho.2018.09.006. Epub 2018 Sep 22.


Prevalence and resource utilization for vocal fold paralysis/paresis after esophagectomy.

Crowson MG, Tong BC, Lee HJ, Song Y, Harpole DH, Jones HN, Cohen S.

Laryngoscope. 2018 Dec;128(12):2815-2822. doi: 10.1002/lary.27252. Epub 2018 Sep 19.


Surgical Outcomes After Neoadjuvant Chemotherapy and Ipilimumab for Non-Small Cell Lung Cancer.

Yang CJ, McSherry F, Mayne NR, Wang X, Berry MF, Tong B, Harpole DH Jr, D'Amico TA, Christensen JD, Ready NE, Klapper JA.

Ann Thorac Surg. 2018 Mar;105(3):924-929. doi: 10.1016/j.athoracsur.2017.09.030. Epub 2017 Dec 16.


Improved Survival of Stage I Non-Small Cell Lung Cancer: A VA Central Cancer Registry Analysis.

Boyer MJ, Williams CD, Harpole DH, Onaitis MW, Kelley MJ, Salama JK.

J Thorac Oncol. 2017 Dec;12(12):1814-1823. doi: 10.1016/j.jtho.2017.09.1952. Epub 2017 Sep 23.


A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Non-small-cell Lung Cancer.

Yang CJ, Kumar A, Klapper JA, Hartwig MG, Tong BC, Harpole DH Jr, Berry MF, D'Amico TA.

Ann Surg. 2019 Jan;269(1):163-171. doi: 10.1097/SLA.0000000000002342.


Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid Tumors.

Anderson KL Jr, Mulvihill MS, Speicher PJ, Yerokun BA, Gulack BC, Nussbaum DP, Harpole DH Jr, D'Amico TA, Berry MF, Hartwig MG.

Ann Thorac Surg. 2017 Oct;104(4):1221-1230. doi: 10.1016/j.athoracsur.2017.05.011. Epub 2017 Jul 29.


Long-term Survival After Surgery Compared With Concurrent Chemoradiation for Node-negative Small Cell Lung Cancer.

Yang CJ, Chan DY, Shah SA, Yerokun BA, Wang XF, D'Amico TA, Berry MF, Harpole DH Jr.

Ann Surg. 2018 Dec;268(6):1105-1112. doi: 10.1097/SLA.0000000000002287.


A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.

Yerokun BA, Yang CJ, Gulack BC, Li X, Mulvihill MS, Gu L, Wang X, Harpole DH, D'Amico TA, Berry MF, Hartwig MG.

J Thorac Cardiovasc Surg. 2017 Aug;154(2):675-686.e4. doi: 10.1016/j.jtcvs.2017.02.065. Epub 2017 Apr 4.


Surgery Versus Optimal Medical Management for N1 Small Cell Lung Cancer.

Yang CJ, Chan DY, Speicher PJ, Gulack BC, Tong BC, Hartwig MG, Kelsey CR, D'Amico TA, Berry MF, Harpole DH.

Ann Thorac Surg. 2017 Jun;103(6):1767-1772. doi: 10.1016/j.athoracsur.2017.01.043. Epub 2017 Apr 25.


Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies.

Yao XI, Wang X, Speicher PJ, Hwang ES, Cheng P, Harpole DH, Berry MF, Schrag D, Pang HH.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djw323. Review.


The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.

Cox ML, Yang CJ, Speicher PJ, Anderson KL, Fitch ZW, Gu L, Davis RP, Wang X, D'Amico TA, Hartwig MG, Harpole DH Jr, Berry MF.

J Thorac Oncol. 2017 Apr;12(4):689-696. doi: 10.1016/j.jtho.2017.01.003. Epub 2017 Jan 8.


The Integrated Comprehensive Care Program: A Novel Home Care Initiative After Major Thoracic Surgery.

Harpole DH.

Semin Thorac Cardiovasc Surg. 2016 Summer;28(2):582-584. doi: 10.1053/j.semtcvs.2016.05.005. Epub 2016 May 31. No abstract available.


Reply to T.-H. Wang et al.

Yang CJ, Chan DY, Wang X, D'Amico TA, Harpole DH, Berry MF.

J Clin Oncol. 2017 Jan;35(1):118-120. Epub 2016 Oct 28. No abstract available.


Reply to D.A. Palma.

Yang CJ, Chan DY, D'Amico TA, Berry MF, Harpole DH.

J Clin Oncol. 2017 Feb 10;35(5):572. doi: 10.1200/JCO.2016.70.2787. Epub 2016 Nov 21. No abstract available.


A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer.

Gulack BC, Yang CJ, Speicher PJ, Yerokun BA, Tong BC, Onaitis MW, D'Amico TA, Harpole DH Jr, Hartwig MG, Berry MF.

Ann Thorac Surg. 2016 Dec;102(6):1814-1820. doi: 10.1016/j.athoracsur.2016.06.032. Epub 2016 Sep 1.


Patterns of Distant Metastases After Surgical Management of Non-Small-cell Lung Cancer.

Torok JA, Gu L, Tandberg DJ, Wang X, Harpole DH Jr, Kelsey CR, Salama JK.

Clin Lung Cancer. 2017 Jan;18(1):e57-e70. doi: 10.1016/j.cllc.2016.06.011. Epub 2016 Jul 5.


Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non-Small Cell Lung Cancer.

Speicher PJ, Fitch ZW, Gulack BC, Yang CJ, Tong BC, Harpole DH, D'Amico TA, Berry MF, Hartwig MG.

Ann Thorac Surg. 2016 Sep;102(3):884-894. doi: 10.1016/j.athoracsur.2016.05.065. Epub 2016 Jul 29.


Impact of Age on Long-Term Outcomes of Surgery for Malignant Pleural Mesothelioma.

Yang CJ, Yan BW, Meyerhoff RR, Saud SM, Gulack BC, Speicher PJ, Hartwig MG, D'Amico TA, Harpole DH, Berry MF.

Clin Lung Cancer. 2016 Sep;17(5):419-426. doi: 10.1016/j.cllc.2016.03.002. Epub 2016 Mar 17.


Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population-Based Analysis.

Yerokun BA, Sun Z, Yang CJ, Gulack BC, Speicher PJ, Adam MA, D'Amico TA, Onaitis MW, Harpole DH, Berry MF, Hartwig MG.

Ann Thorac Surg. 2016 Aug;102(2):416-23. doi: 10.1016/j.athoracsur.2016.02.078. Epub 2016 May 4.


Detection of Occult Micrometastases in Patients With Clinical Stage I Non-Small-Cell Lung Cancer: A Prospective Analysis of Mature Results of CALGB 9761 (Alliance).

Martin LW, D'Cunha J, Wang X, Herzan D, Gu L, Abraham N, Demmy TL, Detterbeck FC, Groth SS, Harpole DH, Krasna MJ, Kernstine K, Kohman LJ, Patterson GA, Sugarbaker DJ, Vollmer RT, Maddaus MA, Kratzke RA.

J Clin Oncol. 2016 May 1;34(13):1484-91. doi: 10.1200/JCO.2015.63.4543. Epub 2016 Feb 29.


Use and Outcomes of Minimally Invasive Lobectomy for Stage I Non-Small Cell Lung Cancer in the National Cancer Data Base.

Yang CF, Sun Z, Speicher PJ, Saud SM, Gulack BC, Hartwig MG, Harpole DH Jr, Onaitis MW, Tong BC, D'Amico TA, Berry MF.

Ann Thorac Surg. 2016 Mar;101(3):1037-42. doi: 10.1016/j.athoracsur.2015.11.018. Epub 2016 Jan 26.


Role of Adjuvant Therapy in a Population-Based Cohort of Patients With Early-Stage Small-Cell Lung Cancer.

Yang CF, Chan DY, Speicher PJ, Gulack BC, Wang X, Hartwig MG, Onaitis MW, Tong BC, D'Amico TA, Berry MF, Harpole DH.

J Clin Oncol. 2016 Apr 1;34(10):1057-64. doi: 10.1200/JCO.2015.63.8171. Epub 2016 Jan 19.


Long-term survival following open versus thoracoscopic lobectomy after preoperative chemotherapy for non-small cell lung cancer.

Yang CF, Meyerhoff RR, Mayne NR, Singhapricha T, Toomey CB, Speicher PJ, Hartwig MG, Tong BC, Onaitis MW, Harpole DH Jr, D'Amico TA, Berry MF.

Eur J Cardiothorac Surg. 2016 Jun;49(6):1615-23. doi: 10.1093/ejcts/ezv428. Epub 2015 Dec 30.


Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer.

Yang CF, Adil SM, Anderson KL, Meyerhoff RR, Turley RS, Hartwig MG, Harpole DH Jr, Tong BC, Onaitis MW, D'Amico TA, Berry MF.

Eur J Cardiothorac Surg. 2016 Jun;49(6):1607-13. doi: 10.1093/ejcts/ezv431. Epub 2015 Dec 30.


The Biology of Pulmonary Metastasis.

Scott CD, Harpole DH.

Thorac Surg Clin. 2016 Feb;26(1):1-6. doi: 10.1016/j.thorsurg.2015.09.001. Review.


A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo.

Saunders LR, Bankovich AJ, Anderson WC, Aujay MA, Bheddah S, Black K, Desai R, Escarpe PA, Hampl J, Laysang A, Liu D, Lopez-Molina J, Milton M, Park A, Pysz MA, Shao H, Slingerland B, Torgov M, Williams SA, Foord O, Howard P, Jassem J, Badzio A, Czapiewski P, Harpole DH, Dowlati A, Massion PP, Travis WD, Pietanza MC, Poirier JT, Rudin CM, Stull RA, Dylla SJ.

Sci Transl Med. 2015 Aug 26;7(302):302ra136. doi: 10.1126/scitranslmed.aac9459.


Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancer.

Yang CF, Gulack BC, Gu L, Speicher PJ, Wang X, Harpole DH, Onaitis MW, D'Amico TA, Berry MF, Hartwig MG.

J Thorac Cardiovasc Surg. 2015 Dec;150(6):1484-92; discussion 1492-3. doi: 10.1016/j.jtcvs.2015.06.062. Epub 2015 Jul 2.


Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer.

Berry MF, Yang CJ, Hartwig MG, Tong BC, Harpole DH, D'Amico TA, Onaitis MW.

Ann Thorac Surg. 2015 Jul;100(1):271-6. doi: 10.1016/j.athoracsur.2015.02.076. Epub 2015 May 16.


Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database.

Meyerhoff RR, Yang CF, Speicher PJ, Gulack BC, Hartwig MG, D'Amico TA, Harpole DH, Berry MF.

J Surg Res. 2015 Jun 1;196(1):23-32. doi: 10.1016/j.jss.2015.01.043. Epub 2015 Jan 29.


Consensus report of a joint NCI thoracic malignancies steering committee: FDA workshop on strategies for integrating biomarkers into clinical development of new therapies for lung cancer leading to the inception of "master protocols" in lung cancer.

Malik SM, Pazdur R, Abrams JS, Socinski MA, Sause WT, Harpole DH Jr, Welch JJ, Korn EL, Ullmann CD, Hirsch FR.

J Thorac Oncol. 2014 Oct;9(10):1443-8. doi: 10.1097/JTO.0000000000000314.


The Society of Thoracic Surgeons practice guidelines on the role of multimodality treatment for cancer of the esophagus and gastroesophageal junction.

Little AG, Lerut AE, Harpole DH, Hofstetter WL, Mitchell JD, Altorki NK, Krasna MJ.

Ann Thorac Surg. 2014 Nov;98(5):1880-5. doi: 10.1016/j.athoracsur.2014.07.069. Epub 2014 Sep 26. Review. No abstract available.


Thoracoscopic left upper lobectomy in patients with internal mammary artery coronary bypass grafts.

Shah AA, Worni M, Onaitis MW, Balderson SS, Harpole DH, D'Amico TA, Berry MF.

Ann Thorac Surg. 2014 Oct;98(4):1207-12. doi: 10.1016/j.athoracsur.2014.05.068. Epub 2014 Aug 7.


Outcomes after pneumonectomy for benign disease: the impact of urgent resection.

Klapper J, Hirji S, Hartwig MG, D'Amico TA, Harpole DH, Onaitis MW, Berry MF.

J Am Coll Surg. 2014 Sep;219(3):518-24. doi: 10.1016/j.jamcollsurg.2014.01.062. Epub 2014 Apr 8.


Sex differences in early outcomes after lung cancer resection: analysis of the Society of Thoracic Surgeons General Thoracic Database.

Tong BC, Kosinski AS, Burfeind WR Jr, Onaitis MW, Berry MF, Harpole DH Jr, D'Amico TA.

J Thorac Cardiovasc Surg. 2014 Jul;148(1):13-8. doi: 10.1016/j.jtcvs.2014.03.012. Epub 2014 Mar 14.


Accuracy of fluorodeoxyglucose-positron emission tomography within the clinical practice of the American College of Surgeons Oncology Group Z4031 trial to diagnose clinical stage I non-small cell lung cancer.

Grogan EL, Deppen SA, Ballman KV, Andrade GM, Verdial FC, Aldrich MC, Chen CL, Decker PA, Harpole DH, Cerfolio RJ, Keenan RJ, Jones DR, D'Amico TA, Shrager JB, Meyers BF, Putnam JB Jr.

Ann Thorac Surg. 2014 Apr;97(4):1142-8. doi: 10.1016/j.athoracsur.2013.12.043. Epub 2014 Feb 25.


Differential prognostic significance of extralobar and intralobar nodal metastases in patients with surgically resected stage II non-small cell lung cancer.

Haney JC, Hanna JM, Berry MF, Harpole DH, D'Amico TA, Tong BC, Onaitis MW.

J Thorac Cardiovasc Surg. 2014 Apr;147(4):1164-8. doi: 10.1016/j.jtcvs.2013.12.015. Epub 2014 Jan 2.


Sleeve lobectomy for non-small cell lung cancer with N1 nodal disease does not compromise survival.

Berry MF, Worni M, Wang X, Harpole DH, D'Amico TA, Onaitis MW.

Ann Thorac Surg. 2014 Jan;97(1):230-5. doi: 10.1016/j.athoracsur.2013.09.016. Epub 2013 Nov 6.


Prospective phase II trial of preresection thoracoscopic mediastinal restaging after neoadjuvant therapy for IIIA (N2) non-small cell lung cancer: results of CALGB Protocol 39803.

Jaklitsch MT, Gu L, Demmy T, Harpole DH, D'Amico TA, McKenna RJ, Krasna MJ, Kohman LJ, Swanson SJ, DeCamp MM, Wang X, Barry S, Sugarbaker DJ; CALGB Thoracic Surgeons.

J Thorac Cardiovasc Surg. 2013 Jul;146(1):9-16. doi: 10.1016/j.jtcvs.2012.12.069.


Pathologic complete response of a malignant peripheral nerve sheath tumor in the lung treated with neoadjuvant Ifosfamide and radiation therapy.

Cuneo KC, Riedel RF, Dodd LG, Harpole DH Jr, Kirsch DG.

J Clin Oncol. 2012 Oct 1;30(28):e291-3. Epub 2012 Aug 6. No abstract available.


Thoracoscopic lobectomy has increasing benefit in patients with poor pulmonary function: a Society of Thoracic Surgeons Database analysis.

Ceppa DP, Kosinski AS, Berry MF, Tong BC, Harpole DH, Mitchell JD, D'Amico TA, Onaitis MW.

Ann Surg. 2012 Sep;256(3):487-93. doi: 10.1097/SLA.0b013e318265819c.


Neighborhood-level socioeconomic determinants impact outcomes in nonsmall cell lung cancer patients in the Southeastern United States.

Erhunmwunsee L, Joshi MB, Conlon DH, Harpole DH Jr.

Cancer. 2012 Oct 15;118(20):5117-23. doi: 10.1002/cncr.26185. Epub 2012 Mar 5.

Supplemental Content

Loading ...
Support Center